Optimizing next-generation RSV prevention in Mali: A cost-effectiveness analysis of pediatric vaccination, maternal vaccination, and extended half-life monoclonal antibody immunoprophylaxis.

• Príomhchruthaitheoirí: Rachel S Laufer (Údar), Ranju Baral (Údar), Andrea G Buchwald (Údar), James D Campbell (Údar), Flanon Coulibaly (Údar), Fatoumata Diallo (Údar), Moussa Doumbia (Údar), Amanda J Driscoll (Údar), Alison P Galvani (Údar), Adama M Keita (Údar), Kathleen M Neuzil (Údar), Samba Sow (Údar), Clint Pecenka (Údar), Justin R Ortiz (Údar), Meagan C Fitzpatrick (Údar)
• Formáid: LEABHAR
• Foilsithe / Cruthaithe: Public Library of Science (PLoS), 2023-01-01T00:00:00Z.
• Ábhair: article
• Rochtain ar líne: Connect to this object online.

Respiratory syncytial virus (RSV) is the most common cause of early childhood lower respiratory tract infection (LRTI) in low- and middle-income countries (LMICs). Maternal vaccines, birth-dose extended half-life monoclonal antibodies (mAbs), and pediatric vaccines are under development for preventi...